| GenScript Was the Most Frequently Referred Biology Contract Research Organization |
| Posted By: yao wang | Posted On: February 2, 2012 5:20 am | Views: 5 |
| GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. |
| |
| Bureaucratic and Technical Hurdles Constraining the Growth of the Indian Smart Cards Market |
| Posted By: Krishna Sharma | Posted On: February 1, 2012 6:53 am | Views: 7 |
| A number of smart card projects such as the UID, E-passports, EPFO, etc have been delayed or cancelled due to problems like lack of funds, technical issues, legal wrangling, etc. |
| |
| Most of the Marketed Monoclonal Antibodies Lack a Patent Protection in India |
| Posted By: Krishna Sharma | Posted On: January 24, 2012 9:50 am | Views: 47 |
| Biosimilar manufacturers are currently free to copy and manufacture most of the globally marketed therapeutic monoclonal antibodies in India |
| |
| The Penetration of Biosimilars in the US Will Vary Across Different Biological Classes |
| Posted By: Krishna Sharma | Posted On: January 12, 2012 6:53 am | Views: 54 |
| The volume penetration of biosimilars in the US will strongly depend upon the complexity of the molecule, the patient pool that it caters and the extent of savings it brings to payers and providers |
| |
| GenScript sponsors 2011 iGEM undergraduate Synthetic Biology competition |
| Posted By: yao wang | Posted On: December 16, 2011 12:53 am | Views: 79 |
| Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams we sponsored in 2011 iGEM undergraduate synthetic biology competition. |
| |
| Synergy Pharmaceuticals Seeks $500 milion in Lawsuit Against Ironwood Pharmaceuticals |
| Posted By: Alex Michelini | Posted On: December 13, 2011 12:25 pm | Views: 174 |
| Accuses Ironwood of Fraud, Unfair Competition and Unjust Enrichment in Gastrointestinal Patent Case |
| |
| Despite its Slow Start, Prospects for Follow-on Biologics Appear Bright in the US |
| Posted By: Krishna sharma | Posted On: December 13, 2011 5:52 am | Views: 174 |
| The performance of HGH biosimilars cannot be taken as an analogue to project the uptake of other biosimilar classes as penetration rates of biosimilars in different biological classes are expected to be different from one another. |
| |
| Biotech Innovator Antonius Schuh Appointed TrovaGene CEO |
| Posted By: Alex Michelini | Posted On: December 7, 2011 5:27 pm | Views: 147 |
| Targets Developing Novel Diagnostics with Company's Trans-renal Moelcular Technologies |
| |
| 4th Annual Pharmaceutical Leadership Summit Gain Momentum |
| Posted By: pharmaleaders | Posted On: November 12, 2011 5:45 am | Views: 273 |
| Narayan Gad of Panacea Biotech, Dr. Chandrashekhar Potkar of Pfizer, Dr B.P.S.Reddy of Hetero, Dr. Kannan Vishwanath of Aanjaneya Lifecare, Shailendra Singh of Percept join the Bandwagon to address at 4th Annual Pharmaceutical Leadership Summit 2011 |
| |
| ReportsnReports.com: US Biologics Market |
| Posted By: paul Nelson | Posted On: October 7, 2011 11:17 am | Views: 252 |
| Freedonia Group’s “US Biologics Market“ is now available at ReportsnReports.com. |
| |
|
|
Business
![[Valid RSS]](images/valid-rss-rogers.png "Validate my RSS feed")
